Showing results (1651-1660 of 9,761) with videos related to

Sort By:
Pageof 977
Scandinavian Journal of Gastroenterology|January 1, 1987
Fasting and meal-stimulated plasma levels of neurotensin in obese patients after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratioJ H Pedersen, T I Sørensen, B Andersen, et al.
Scandinavian Journal of Gastroenterology|January 1, 1987
Estimation of the 3-day faecal fat excretion and fat concentration as a differential test of malabsorption and maldigestionN T Pedersen, H Halgreen, H Worning
Scandinavian Journal of Gastroenterology|June 1, 2022
Gastric lesions in patients with autoimmune metaplastic atrophic gastritis: a retrospective study in a single centerHaiyi Hu, Rongxue Li, Linlin Shao, et al.
Scandinavian Journal of Gastroenterology|May 9, 2022
Gastric cancer screening: a systematic review and meta-analysisLídia Faria, João Carlos Silva, Marta Rodríguez-Carrasco, et al.
Scandinavian Journal of Gastroenterology|January 6, 2018
Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre StudyLina Lindström, Kristin K Jørgensen, Kirsten M Boberg, et al.
Scandinavian Journal of Gastroenterology|December 6, 2018
Long term outcome of EUS-based strategy for suspected choledocholithiasis but negative CT findingJae Keun Park, Jong Kyun Lee, Ju Il Yang, et al.
Scandinavian Journal of Gastroenterology|March 16, 2018
Outpatient management of acute uncomplicated diverticulitis results in health-care cost savingsDaniel Isacson, Karl Andreasson, Maziar Nikberg, et al.
Scandinavian Journal of Gastroenterology|March 17, 2018
Outcome for biliary atresia patients treated at a low-volume centreKristin Bjørnland, Maren Hinna, Gunnar Aksnes, et al.
Scandinavian Journal of Gastroenterology|March 17, 2018
Microscopic colitis in patients with ulcerative colitis or Crohn's disease: a retrospective observational study and review of the literatureAnna Wickbom, Johan Bohr, Nils Nyhlin, et al.
Scandinavian Journal of Gastroenterology|June 22, 2022
Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective studyAndreas Blesl, Wolfgang Petritsch, Lukas Binder, et al.
Pageof 977